FEMARA 2.5 MG
| Other Names: | LETROZOLE |
| Dosage: | 2.5 MG |
$320.00
Femara (letrozole) lowers estrogen levels in postmenopausal women, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.
Description
FEMARA 2.5 MG
Femara 2.5 MG is a medication that contains the active ingredient letrozole, which is an aromatase inhibitor. It is primarily used to treat breast cancer in postmenopausal women, as it works by reducing the amount of estrogen produced in the body, which can help slow or stop the growth of breast cancer cells. Femara 2.5 MG is typically taken orally in tablet form, and the dosage and duration of treatment will depend on the stage and type of breast cancer being treated and the individual’s response to the medication. In some cases, Femara 2.5 MG may also be used off-label to treat infertility in women by stimulating ovulation. It is important to follow the dosing instructions provided by a healthcare professional when taking Femara 2.5 MG, and to be aware of the potential side effects associated with this medication, such as hot flashes, joint pain, and nausea.
